Celcuity (CELC) Interest Coverage Ratio (2017 - 2025)
Celcuity (CELC) reported Interest Coverage Ratio of 13.92 for Q4 2025, down 14.59% on a YoY basis from 16.29 in Q4 2024, and up 249.24% quarter-over-quarter from 9.33 in Q3 2025.
Celcuity (CELC) Interest Coverage Ratio (2017 - 2025) Analysis & Trends
Celcuity has reported Interest Coverage Ratio for 9 years, with the latest figure at 13.92 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio fell 14.59% year-over-year to 13.92; the trailing twelve-month figure through Dec 2025 stood at 2.17 (up 5.05% YoY), and the FY2025 full-year result was 2.17, up 5.05% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 13.92, up from 9.33 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 36.11 in Q4 2021, with the low at 116323.75 in Q1 2021.
- Historically, Interest Coverage Ratio has averaged 5825.01 across 5 years, with a median of 13.33 in 2021.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio sank 147.54% — and 2024, when it surged 215.4%.
- Celcuity's Interest Coverage Ratio stood at 36.11 in 2021, then tumbled by 147.54% to 17.17 in 2022, then gained by 17.75% to 14.12 in 2023, then surged by 215.4% to 16.29 in 2024, then dropped by 14.59% to 13.92 in 2025.
- The last three Interest Coverage Ratio figures came in at 13.92 (Q4 2025), 9.33 (Q3 2025), and 13.74 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -258.33 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 11.79 |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 13.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.92 |
| Sep 30, 2025 | -9.33 |
| Jun 30, 2025 | -13.74 |
| Mar 31, 2025 | -11.35 |
| Dec 31, 2024 | 16.29 |
| Sep 30, 2024 | -8.99 |
| Jun 30, 2024 | -10.75 |
| Mar 31, 2024 | -16.05 |
| Dec 31, 2023 | -14.12 |
| Sep 30, 2023 | -13.77 |
| Jun 30, 2023 | -11.45 |
| Mar 31, 2023 | -10.10 |
| Dec 31, 2022 | -17.17 |
| Sep 30, 2022 | -19.80 |
| Jun 30, 2022 | -21.08 |
| Mar 31, 2022 | -17.26 |
| Dec 31, 2021 | 36.11 |
| Sep 30, 2021 | -12.93 |
| Jun 30, 2021 | -34.88 |
| Mar 31, 2021 | -116,323.75 |